Determination of Posture in Patients With Restrictive and Obstructive Lung Disease

NCT ID: NCT06306482

Last Updated: 2024-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-07

Study Completion Date

2026-03-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine posture and posture related factors in patients with restrictive and obstructive lung disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is aimed at investigating posture and posture related factors according to both type of disease and severity of disease in patients with restrictive and obstructive lung disease. The secondary purpose is to develop a model that determines correlations between posture and functional exercise capacity, respiratory and peripheral muscle strength, tightness of muscle, balance, and physical activity for each disease that will be included in this study. In accordance with these purposes, for each group, at least 15 patients with obstructive and restrictive lung disease will be included according to the inclusion and exclusion criteria for each disease, and 15 healthy controls will be included. Tests and questionnaires will be used in order to determine the severity of diseases. Lung function test and respiratory and peripheral muscle strength test will be performed. Time and Go test (TUG) and One minute sit to stand test will be performed. To evaluate the accessory respiratory muscles, a muscle tightness test will be performed for each muscle. Six Minute Walk Test (6 MWT) will be performed with an armband that measures energy expenditure for functional exercise capacity. To evaluate posture, the Corbin Postural Assessment Scale and photographic analysis will be used. Photographical analysis using software in lateral, posterior, and anterior views will be used for the cervical, thoracic, and lumbar regions. For angular and length measurements, anatomical landmarks will be determined and calculated in the regions. According to the results to be obtained, changes in posture according to the regions and posture related factors will be determined for each disease. It will guide professional working in this field.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Diseases, Obstructive Lung Diseases Postural; Defect

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Patients with chronic obstructive lung disease, asthma, cystic fibrosis and bronchiectasis.

No interventions assigned to this group

Group B

Patients with diffuse parenchymal lung diseases

No interventions assigned to this group

control group

healthy aged matched individuals.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 55 years old,
* Stage 1-2-3-4 according to the GOLD,
* Being clinically stable for the last 4 weeks.


* Being diagnosed with CF as a result of two sweat tests,
* Being over 18 years old.


* Diagnosed with asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA),
* Clinically stable for the last 1 month
* Being over 18 years old.


* Being over 18 years old,
* Being diagnosed with bronchiectasis other than cystic fibrosis,
* Being clinically stable for the last 1 month.


* Being diagnosed with diffuse parenchymal lung according to American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,
* Being over 18 years old,
* Having volunteered to participate in the research,
* To be clinically stable and to have comorbid conditions (such as hypertension, diabetes) under control,

Exclusion Criteria

* Receiving long-term oxygen therapy,
* Having central and peripheral vestibular disease,
* Communication problems, known mental and cognitive problems,
* Having undergone any surgical intervention related to the spine within the last six months,


* Being in acute pulmonary exacerbation period,
* Receiving long-term oxygen therapy,
* Having undergone any surgical intervention related to the spine within the last six months,


* Change in medication for the last 1 month.
* Having undergone any surgical intervention related to the spine in the last six months,


* Receiving long-term oxygen therapy,
* Having undergone any surgical intervention related to the spine in the last six months.


* Having undergone any surgical intervention related to the spine within the last six months,
* Having exacerbation in the last 3 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aynur Demirel

Principal investigator; PT, PhD, Assoc. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aynur Demirel

Role: PRINCIPAL_INVESTIGATOR

Hacettepe University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aynur Demirel

Ankara, , Turkey (Türkiye)

Site Status

Hacettepe University

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aynur Demirel, PhD

Role: CONTACT

+905545295057

Hidaye Yamikan, PT,MSc

Role: CONTACT

+905349898724

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aynur Demirel

Role: primary

+905545295057 ext. 178

hidaye yamikan

Role: backup

+905349898724

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SBA 23/390

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.